Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Anthropic’s growth slows ahead of IPO as AI spending bill nears $900bn

      Dario Amodei, CEO of Anthropic, speaking at a tech conference podium, wearing a suit and addressing the audience.

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Commonwealth Games generated £223m for Scotland

      Nighttime fireworks display over a river, with colorful bursts reflecting on the water and city buildings in the background.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      London Watch Week – The City Edition mega preview, featuring Christopher Ward, Nomos and more

      The Royal Exchange and Bank of England building in Londons financial district, with modern skyscrapers behind.

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Pension Report
  • Newsletters
  • Latest Paper

Sanofi

  • Pharma giants GSK, Pfizer and Sanofi granted supreme court hearing in Zantac cancer lawsuits

    pharma

    Delaware’s top court is set to hear an appeal from GSK and other pharmaceutical giants to throw out over 70,000 lawsuits alleging that the now-discontinued heartburn drug Zantac caused cancer. The companies, which also include Pfizer and Sanofi, are challenging a lower court ruling that allowed expert testimony claiming Zantac causes cancer – a link [...]

    GSK higher after settling Zantac cases
  • GSK wins latest Zantac trial as jury finds drug did not cause woman’s cancer

    pharma

    GSK - formerly GlaxoSmithKline - has won its latest trial over whether its most popular drug caused cancer on Monday, after a jury found it was not the root cause of an American woman's illness.

    GSK said on Monday its blood cancer drug Blenrep, when used as a second-line treatment in patients with myeloma, met its primary goal.
  • GSK: How much could the Zantac lawsuits cost?

    Pharma

    Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.

    Last month, Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares. 
  • Are LVMH, Nestle, L’Oreal and Hermes Europe’s alternative to Microsoft, Apple, Nvidia and Tesla?

    April 9, 2024

    Much has been made of the 'Magnificent Seven' tech stocks - Meta, Apple, Amazon. Alphabet, Microsoft, Nvidia and Tesla - which have dominated the US market amid a boom in demand for AI and, until recently, more optimism over potential interest rate cuts.

Trending Articles

  • Tesco retreats from Europe with £1.5bn sale of Czech and Slovak divisions

  • Work-from-home rules are holding back young workers, says PwC boss

  • Britain’s oldest brewery unveils £15m plan to move to new site

  • Treasury minister: ‘I don’t think employers are working people’

  • No bids for West Ham’s London Stadium amid reported £50m asking price

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Privacy settings
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited